Previously, we have reported that etodolac, a selective Cox-2 inhibitor, induced upregulation of E-cadherin and an in vivo growth inhibitory effect in high-grade human bladder cancer cell line T24 (Okamoto et al, 2008). This evidence concerns the gene CDH1 and urinary bladder cancer.